These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21993309)

  • 1. Comparison of alternative interpretive criteria for the HIV-1 Western blot and results of the Multispot HIV-1/HIV-2 Rapid Test for classifying HIV-1 and HIV-2 infections.
    Nasrullah M; Ethridge SF; Delaney KP; Wesolowski LG; Granade TC; Schwendemann J; Boromisa RD; Heffelfinger JD; Owen SM; Branson BM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S23-7. PubMed ID: 21993309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Multispot EIA with Western blot for confirmatory serodiagnosis of HIV.
    Torian LV; Forgione LA; Punsalang AE; Pirillo RE; Oleszko WR
    J Clin Virol; 2011 Dec; 52 Suppl 1():S41-4. PubMed ID: 21995935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established HIV-1 infection and blood donors.
    Wesolowski LG; Delaney KP; Hart C; Dawson C; Owen SM; Candal D; Meyer WA; Ethridge SF; Branson BM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S45-9. PubMed ID: 21995934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay.
    Chavez P; Wesolowski L; Patel P; Delaney K; Owen SM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S51-5. PubMed ID: 21983253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of supplemental testing with the Multispot HIV-1/HIV-2 Rapid Test and APTIMA HIV-1 RNA Qualitative Assay to resolve specimens with indeterminate or negative HIV-1 Western blots.
    Linley L; Ethridge SF; Oraka E; Owen SM; Wesolowski LG; Wroblewski K; Landgraf KM; Parker MM; Brinson M; Branson BM
    J Clin Virol; 2013 Dec; 58 Suppl 1():e108-12. PubMed ID: 24342469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an alternative supplemental testing strategy for HIV diagnosis by retrospective analysis of clinical HIV testing data.
    Styer LM; Sullivan TJ; Parker MM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S35-40. PubMed ID: 22018662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of an alternative laboratory-based algorithm for HIV diagnosis in a high-risk population.
    Delaney KP; Heffelfinger JD; Wesolowski LG; Owen SM; Meyer WA; Kennedy S; Uniyal A; Kerndt PR; Branson BM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S5-10. PubMed ID: 22019251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections.
    Masciotra S; McDougal JS; Feldman J; Sprinkle P; Wesolowski L; Owen SM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S17-22. PubMed ID: 21981983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Bio-Rad Multispot HIV-1/HIV-2 Rapid Test as an alternative to Western blot for confirmation of HIV infection.
    Cárdenas AM; Baughan E; Hodinka RL
    J Clin Virol; 2013 Dec; 58 Suppl 1():e97-e103. PubMed ID: 24113294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of the Bio-Rad Geenius HIV-1/2 Confirmatory Assay and the Bio-Rad Multispot HIV-1/2 Rapid Test as an alternative differentiation assay for CLSI M53 algorithm-I.
    Malloch L; Kadivar K; Putz J; Levett PN; Tang J; Hatchette TF; Kadkhoda K; Ng D; Ho J; Kim J
    J Clin Virol; 2013 Dec; 58 Suppl 1():e85-91. PubMed ID: 24342484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indeterminate human immunodeficiency virus western blot results in Iranian patients with discordant screening assay results.
    Ravanshad M; Mahboudi F; Sabahi F; Bayanolhagh S
    Saudi Med J; 2006 Aug; 27(8):1130-3. PubMed ID: 16883439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of a fourth-generation HIV screening assay and an alternative HIV diagnostic testing algorithm.
    Nasrullah M; Wesolowski LG; Meyer WA; Owen SM; Masciotra S; Vorwald C; Becker WJ; Branson BM
    AIDS; 2013 Mar; 27(5):731-7. PubMed ID: 23135170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of human immunodeficiency virus (HIV) type 1 and 2 recombinant strip immunoblot assay to resolve enzyme immunoassay anti-HIV-2-repeatably reactive samples after anti-HIV-1/2 combination enzyme immunoassay screening.
    Tobler LH; Kaufman E; Gefter N; Schable C; Busch MP
    Transfusion; 1997 Sep; 37(9):921-5. PubMed ID: 9308638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of the new HIV-1/2 diagnostic algorithm in Florida's public health testing population: a review of the first five months of utilization.
    Bennett B; Neumann D; Fordan S; Villaraza R; Crowe S; Gillis L
    J Clin Virol; 2013 Dec; 58 Suppl 1():e29-33. PubMed ID: 24342476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpretive criteria used to report western blot results for HIV-1-antibody testing--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Oct; 40(40):692-5. PubMed ID: 1656186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the indeterminate results of characterization and verification of HIV antibody from Western blot test].
    Bao ZY; Liu YJ; Wang HY; Wang QL; Luo Q; Liu YD; Ma F; Xing YC; Tong YG; Li JY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 May; 29(5):478-81. PubMed ID: 18956682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of two commercial human immunodeficiency virus serological tests in cases with indeterminate Western blot results.
    Huang LJ; Liu CY; Chu SC; Wong WW; Lin YC; Liu WT; Chan YJ
    J Microbiol Immunol Infect; 2006 Jun; 39(3):219-24. PubMed ID: 16783452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of rapid HIV assays as supplemental tests in specimens with repeatedly reactive screening immunoassay results not confirmed by HIV-1 Western blot.
    Wesolowski LG; Delaney KP; Meyer WA; Blatt AJ; Bennett B; Chavez P; Granade TC; Owen M
    J Clin Virol; 2013 Sep; 58(1):240-4. PubMed ID: 23838670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical performance of the Multispot HIV-1/HIV-2 rapid test to correctly differentiate HIV-2 from HIV-1 infection in screening algorithms using third and fourth generation assays and to identify cross reactivity with the HIV-1 Western Blot.
    Ramos EM; Harb S; Dragavon J; Coombs RW
    J Clin Virol; 2013 Dec; 58 Suppl 1(0 1):e104-7. PubMed ID: 24342468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of combining World Health Organization and Center for Disease Control criteria to resolve indeterminate human immunodeficiency virus type-1 Western blot results.
    Tebourski F; Slim A; Elgaaied A
    Diagn Microbiol Infect Dis; 2004 Jan; 48(1):59-61. PubMed ID: 14761723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.